Merck Animal Health’s Acquisition of Prondil S.A.

Guyer & Regules and Posadas, Posadas & Vecino advised on the transaction

Intervet finalized the acquisition of Prondil S.A.

Intervet Inc., doing business as Merck Animal Health, develops, manufactures, and markets a range of veterinary medicines and services. The company, led by K. J. Varma, Scott Bormann, Rick Sibbel, Jamie Lehman and Madeleine Stahl, offers products for the prevention, treatment, and control of diseases in major farm and companion animal species.

Prondil S.A., founded in the early 90´s by former executives of Cooper Animal Health (ex Wellcome Research Lab.), the company is based in Montevideo.

Guyer & Regules advised Intervet Holding B.V. with Juan Manuel Mercant (Picture), Marcos A. Payssé, Guzmán Rodríguez Carrau and Pilar Alvarez.

Posadas, Posadas & Vecino advised the selling shareholsers with Luis Nin, Tomás Gurméndez, Cecilia Demarco and Valeria Techera.

Involved fees earner: Juan Manuel Mercant – Guyer & Regules; Marcos Payssé – Guyer & Regules; Guzmán Rodríguez Carrau – Guyer & Regules; Pilar Alvarez – Guyer & Regules; Luis Nin Estévez – Posadas, Posadas & Vecino; Tomás Gurméndez – Posadas, Posadas & Vecino; Valeria Techera – Posadas, Posadas & Vecino; Cecilia Demarco – Posadas, Posadas & Vecino;

Law Firms: Guyer & Regules; Posadas, Posadas & Vecino;

Clients: Intervet International BV; Prondil S.A.;

Print Friendly, PDF & Email

Author: Ambrogio Visconti.